本頁面由Tiger Trade Technology Pte. Ltd.提供服務

武田製藥

18.91
-0.1400-0.73%
盤後18.960.0500+0.26%19:51 EDT
成交量:296.07萬
成交額:5,604.66萬
市值:601.82億
市盈率:-59.39
高:19.01
開:18.80
低:18.80
收:19.05
52周最高:19.10
52周最低:12.99
股本:31.83億
流通股本:30.92億
量比:1.15
換手率:0.10%
股息:0.64
股息率:3.37%
每股收益(TTM):-0.3184
每股收益(LYR):-0.3042
淨資產收益率:-2.26%
總資產收益率:2.69%
市淨率:1.25
市盈率(LYR):-62.15

資料載入中...

2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/28

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities